Rachael Dippold Ph.D.

Popular Topics

Intellectual Property

DETAILS

United States

www.finnegan.com

+1 202 4084000

AUTHORS CONTENT

Counting Patents, Not Progress: Another Misdiagnosis By I-MAK

United States IP

Cancer Immunotherapy Pilot Program Set To Expire In June Unless Extended

United States Healthcare

USPTO Seeks Public Feedback And Ideas At Subject Matter Eligibility Roundtables

United States IP

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More